AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 29121415
Drug: Trametinib 2
RxNorm normalized name: trametinib 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trametinib 2 mg once daily until progressive disease, death, or unacceptable toxicity
Trial: 23536942
Drug: Bosentan 125
RxNorm normalized name: bosentan 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bosentan 125 mg/day for 4 weeks, then randomized to 125 mg/day (Group 1) or 250 mg/day (Group 2) for 12 weeks.
Trial: 23536942
Drug: Bosentan 125
RxNorm normalized name: bosentan 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bosentan 125 mg/day (Group 1)
Trial: 23536942
Drug: Bosentan 250
RxNorm normalized name: Bosentan
DrugBank: Bosentan (DB00559)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bosentan 250 mg/day (Group 2)
Trial: 20967979
Drug: Local antibacterial
RxNorm normalized name: Dermoplast Antibacterial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local antibacterial treatment consisting of bladder ionophoresis, vaginal exposure to estrogens, and vibromagnetic action of RECTOMASSAGER attachment and AMUS‐01‐INTRAMAG device
Trial: 18687385
Drug: Valproate monotherapy
RxNorm normalized name: valproate
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Valproate monotherapy for 6 weeks
Trial: 12526235
Drug: Tracheal gas
RxNorm normalized name: bovine type II collagen (tracheal cartilage)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tracheal gas insufflation (flow rate 6 L/min)
Trial: 8102428
Drug: Dexamethasone (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (0.4 mg/kg every 12 h for 2 days)
Trial: 3463350
Drug: First 3
RxNorm normalized name: 3-Step First Aid Kit KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First 3 weeks of treatment (abstinent or not)
Trial: 3463350
Drug: Remaining 3
RxNorm normalized name: Remain Gold
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remaining 3 weeks of treatment (moderate drinker or not)
Trial: 29379278
Drug: Platelet-rich plasma
RxNorm normalized name: PLATELET-RICH PLASMA, AUTOLOGOUS
DrugBank: Platelet Rich Plasma (DB19295)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platelet-rich plasma (PRP) injection (7 mL PRP solution)
Trial: 29379278
Drug: Prolotherapy (PRL)
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolotherapy (PRL) injection (7 mL 25% dextrose)
Trial: 24623027
Drug: Diabetes Education
RxNorm normalized name: Diabetic Tussin EX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diabetes Education treatment
Trial: 22555622
Drug: Venlafaxine (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine (75 mg per day)
Trial: 18567918
Drug: Cilostazol 100
RxNorm normalized name: cilostazol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilostazol 100 mg twice daily for 14 days
Trial: 16266356
Drug: Oxymorphone ER
RxNorm normalized name: oxymorphone Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxymorphone ER 40 mg
Trial: 16266356
Drug: Oxymorphone ER
RxNorm normalized name: oxymorphone Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxymorphone ER 20 mg
Trial: 16266356
Drug: Oxymorphone ER
RxNorm normalized name: oxymorphone Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxymorphone ER 20 mg and 40 mg
Trial: 8871884
Drug: Famciclovir (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famciclovir (10 day course, oral)
Trial: 1373429
Drug: Chemotherapy followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chemotherapy followed by radiotherapy (2 cycles)
Trial: 1373429
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with radiosensitizing agent (3 cycles)
Trial: 29903551
Drug: Conventional chemoradiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional chemoradiation treatment (60 Gy in 30 fractions)
Trial: 24025633
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (9.7 to 10.7 mg/d)
Trial: 24025633
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (placebo, 1.3 to 1.4 mg/d)
Trial: 20080256
Drug: Continuous wound
RxNorm normalized name: Uniphyllin Continus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous wound infusion of bupivacaine
Trial: 19751371
Drug: Frovatriptan 2.5
RxNorm normalized name: frovatriptan 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frovatriptan 2.5 mg twice daily
Trial: 19751371
Drug: Frovatriptan 2.5
RxNorm normalized name: frovatriptan 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frovatriptan 2.5 mg once daily
Trial: 7524908
Drug: Intravenous immunoglobulins
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulins (Ig) at a dose of 500 mg/kg every 2 weeks for the first 100 days post-BMT
Trial: 7524908
Drug: Detection of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Detection of anti-HCV antibodies
Trial: 3365327
Drug: Deceptive administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Deceptive administration of placebo
Trial: 3365327
Drug: Double-blind administration
RxNorm normalized name: Io-Blend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double-blind administration of placebo
Trial: 29618329
Drug: Digital exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digital exercise prescription tool with standard lifestyle consultation for 3 months
Trial: 20639738
Drug: Pregabalin 300
RxNorm normalized name: pregabalin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin 300 mg + TENS
Trial: 20639738
Drug: Pregabalin 600
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pregabalin 600 mg + TENS
Trial: 20639738
Drug: Pregabalin 300
RxNorm normalized name: pregabalin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin 300 mg + TENS placebo
Trial: 20639738
Drug: Pregabalin 600
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pregabalin 600 mg + TENS placebo
Trial: 20806385
Drug: Non-ablative 1,550
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-ablative 1,550 nm fractional laser therapy (FLT) - 4-5 sessions at 15 mJ/microbeam, 14-20% coverage
Trial: 20806385
Drug: Triple topical
RxNorm normalized name: Triple Paste Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple topical therapy (TTT) - hydroquinone 5%, tretinoin 0.05%, triamcinolone acetonide 0.1% cream, applied once daily for 15 weeks
Trial: 9832694
Drug: Calcium-channel antagonists
RxNorm normalized name: Channel catfish
DrugBank: Channel catfish (DB15548)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium-channel antagonists therapy
Trial: 2730323
Drug: Antibiotic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic treatment for one day (n = 23)
Trial: 2730323
Drug: Antibiotic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic treatment for four days (n = 27)
Trial: 2730323
Drug: Antibiotic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic treatment for four days (n = 14)
Trial: 29789414
Drug: Personalized fitting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Personalized fitting device using 3D scanning solution
Trial: 27284581
Drug: Ultracaine DS
RxNorm normalized name: Uretron DS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultracaine DS Forte (treatment group)
Trial: 19864082
Drug: Androgen suppression
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Androgen suppression therapy (AST) plus radiation therapy (RT)
Trial: 15653378
Drug: Simvastatin 20
RxNorm normalized name: simvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 20 mg/day for 6 months
Trial: 8554941
Drug: Ethanol 0.3
RxNorm normalized name: ethanol 0.3 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol 0.3 g kg-1 before an evening meal
Trial: 8554941
Drug: Ethanol 0.3
RxNorm normalized name: ethanol 0.3 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol 0.3 g kg-1 after an evening meal
Trial: 6105520
Drug: Human insulin
RxNorm normalized name: Human insulin
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human insulin (low dose)
Trial: 6105520
Drug: Human insulin
RxNorm normalized name: Human insulin
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human insulin (high dose)
Trial: 6105520
Drug: Porcine insulin
RxNorm normalized name: Porcine insulin
DrugBank: Insulin pork (DB00071)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Porcine insulin (low dose)
Trial: 6105520
Drug: Porcine insulin
RxNorm normalized name: Porcine insulin
DrugBank: Insulin pork (DB00071)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Porcine insulin (high dose)
Trial: 6105520
Drug: Human insulin
RxNorm normalized name: Human insulin
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human insulin (intravenous infusion)
Trial: 6105520
Drug: Porcine insulin
RxNorm normalized name: Porcine insulin
DrugBank: Insulin pork (DB00071)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Porcine insulin (intravenous infusion)
Trial: 26603627
Drug: Loss-framed message
RxNorm normalized name: semaglutide
DrugBank: Semaglutide (DB13928)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Loss-framed message promoting calcium supplements
Trial: 20806117
Drug: Apixaban 20
RxNorm normalized name: Apixaban
DrugBank: Apixaban (DB06605)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Apixaban 20 mg once daily
Trial: 15822418
Drug: Sufentanil TCI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil TCI (0.08-0.1 ng/ml)
Trial: 15822418
Drug: i.v. morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. morphine (Bolus group)
Trial: 11337713
Drug: Ropivacaine 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 75 mg in 20 mL of saline solution
Trial: 11337713
Drug: Morphine 2
RxNorm normalized name: apomorphine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 2 mg in 20 mL of saline solution
Trial: 11337713
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution 20 mL
Trial: 181258
Drug: Intravenous Intralipid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous Intralipid
Trial: 181258
Drug: Intravenous egg
RxNorm normalized name: EGG
DrugBank: Egg (DB10529)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous egg phospholipid
Trial: 30910373
Drug: NAE (Net
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NAE (Net Acid Excretion) measurement
Trial: 30910373
Drug: Insulin resistance,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin resistance, dietary potential renal acid load, and metabolically active medications (e.g., metformin, allopurinol, nonstatin lipid agents)
Trial: 16688811
Drug: 3‐DCRT combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3‐DCRT combined with FOLFOX4 chemotherapy
Trial: 11304939
Drug: Dimetindene 0.1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dimetindene 0.1% (Fenistil Nasal Spray)
Trial: 11304939
Drug: Levocabastine 0.05%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levocabastine 0.05% solution
Trial: 9322630
Drug: Active management
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active management of labor with epidural analgesics
Trial: 9322630
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care control protocol with epidural analgesics
Trial: 8140565
Drug: Hydrochlorothiazide (E)
RxNorm normalized name: Hydrochlorothiazide
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (E) 25‐50 mg per day
Trial: 8140565
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of altizide 15 mg and aldactone 25 mg (A) 1 or 2 tablets per day
Trial: 31311674
Drug: Rimegepant (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rimegepant (75 mg orally disintegrating tablet)
Trial: 8767563
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg clorazepate dipotassium
Trial: 1684196
Drug: Ciprofloxacin (iv
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin (iv or oral)
Trial: 6356321
Drug: Sucralfate, 1
RxNorm normalized name: Sucralfate, 1 g oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralfate, 1 g four times daily
Trial: 6356321
Drug: Cimetidine, 200
RxNorm normalized name: Cimetidine, 200 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine, 200 mg three times daily and 400 mg at night
Trial: 28924075
Drug: Physiotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiotherapy plus 30 mg/day edoxaban
Trial: 16628625
Drug: 30-mg clevudine
RxNorm normalized name: zinc pyrithione
DrugBank: Pyrithione (DB06815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30-mg clevudine
Trial: 16628625
Drug: 50-mg clevudine
RxNorm normalized name: zinc pyrithione
DrugBank: Pyrithione (DB06815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50-mg clevudine
Trial: 4909360
Drug: Phenobarbitone (administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenobarbitone (administered orally for 3 days)
Trial: 4909360
Drug: Placebo linctus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo linctus (administered orally for 3 days)
Trial: 22417197
Drug: FRIENDS for
RxNorm normalized name: Aluminum Zirconium Tetrachlorohydrex GLY 17.8 g in 100 g TOPICAL STICK [DEGREE GIRL FRIENDS FOREVER ANTIPERSPIRANT AND DEODORANT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FRIENDS for life program (manualized individual cognitive behavioral treatment)
Trial: 20861377
Drug: Hydrocortisone administered
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Hydrocortisone administered 75 min before scanning
Trial: 20861377
Drug: Hydrocortisone administered
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Hydrocortisone administered 285 min before scanning
Trial: 15853098
Drug: Ca(OH)2 solution
RxNorm normalized name: IMMUNOGLOBULIN G (HUMAN-MOUSE MONOCLONAL CA2 HEAVY CHAIN ANTI-HUMAN TUMOR NECROSIS FACTOR), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL CA2 LIGHT CHAIN, DIMER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ca(OH)2 solution
Trial: 10435146
Drug: Oral Balance
RxNorm normalized name: Biotene Oral Balance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Balance gel and Biotene toothpaste
Trial: 10435146
Drug: Placebo (carboxymethylcellulose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (carboxymethylcellulose gel and commercial toothpaste)
Trial: 7852526
Drug: 0.05 mg/kg.day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05 mg/kg.day gallium nitrate
Trial: 7852526
Drug: 0.25 mg/kg.day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg/kg.day gallium nitrate
Trial: 7852526
Drug: 0.5 mg/kg.day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/kg.day gallium nitrate
Trial: 2087618
Drug: Nifluril (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifluril (400 mg daily, morniflumate)
Trial: 2087618
Drug: Amoxicilline (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicilline (50 mg/kg daily)
Trial: 358728
Drug: Rivanol combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivanol combined with half dose PGF2alpha
Trial: 26489835
Drug: Inspiratory muscle
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inspiratory muscle training (IMT) twice daily for 2 weeks at 30% of maximal inspiratory pressure, in addition to standard postoperative physiotherapy.
Trial: 22339611
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of CBT and SSRIs
Trial: 20730073
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (Candesartan and CCBs)
Trial: 11892706
Drug: Celecoxib 100
RxNorm normalized name: celecoxib 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 100 mg BID for 6 weeks (OA)
Trial: 11892706
Drug: Diclofenac 50
RxNorm normalized name: DICLOFENAC 50MG/MISOPROSTOL 200MCG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 50 mg BID or TID for 6 weeks (OA)
Trial: 11892706
Drug: Celecoxib 200
RxNorm normalized name: celecoxib 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 200 mg BID for 24 weeks (RA)
Trial: 11892706
Drug: Diclofenac 75
RxNorm normalized name: CAPSAICIN 0.025%/DICLOFENAC 75MG KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 75 mg BID for 24 weeks (RA)
Trial: 10333347
Drug: valsartan 10
RxNorm normalized name: valsartan 103 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: valsartan 10 mg
Trial: 10333347
Drug: valsartan 40
RxNorm normalized name: valsartan 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: valsartan 40 mg
Trial: 7795831
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of weight loss and sodium reduction
Trial: 19614621
Drug: Masitinib (3,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Masitinib (3, 4.5, and 6 mg/kg/day)
Trial: 17968637
Drug: Tibetan medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tibetan medicine
Trial: 15311147
Drug: Telmisartan (40-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan (40-80 mg)
Trial: 15311147
Drug: Telmisartan (40-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan (40-80 mg) after missed dose
Trial: 15311147
Drug: Valsartan (80-160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan (80-160 mg)
Trial: 15311147
Drug: Valsartan (80-160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan (80-160 mg) after missed dose
Trial: 9501889
Drug: Sertraline during
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline during the luteal phase
Trial: 31645364
Drug: Use of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Use of a web-based decision support tool for antidepressant treatment
Trial: 26842902
Drug: Rivaroxaban 10
RxNorm normalized name: rivaroxaban 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivaroxaban 10 mg once daily for CrCl ≥ 50 ml/min or 7.5 mg once daily for CrCl ≥ 30 ml/min and < 50 ml/min for 45 days
Trial: 24576226
Drug: Recombinant follicle-stimulating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant follicle-stimulating hormone (rFSH)
Trial: 31575059
Drug: Low-dose POP
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose POP (8.7 mg/d)
Trial: 31575059
Drug: Medium-dose POP
RxNorm normalized name: Medium-Chain Triglycerides
DrugBank: Medium-chain triglycerides (DB13959)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium-dose POP (15.2 mg/d)
Trial: 31575059
Drug: High-dose POP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose POP (37.2 mg/d)
Trial: 19483236
Drug: Translocation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Translocation of the proximal nerve stump into an adjacent subcutaneous vein
Trial: 15562051
Drug: Selective spinal
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective spinal anesthesia (SSA) with 4 mg of hyperbaric bupivacaine
Trial: 7542301
Drug: Miconazole and
RxNorm normalized name: Miconazole and zinc oxide only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Miconazole and G-CSF administered simultaneously (Group I)
Trial: 7542301
Drug: Miconazole administered
RxNorm normalized name: Miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Miconazole administered later during G-CSF administration (Group II)
Trial: 7542301
Drug: Only miconazole
RxNorm normalized name: Product containing only miconazole (medicinal product)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Only miconazole administered (Group III)
Trial: 7542301
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with neutrophil counts <500/microliters throughout miconazole administration (Group I)
Trial: 7542301
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with neutrophil counts <500/microliters throughout miconazole administration (Group II)
Trial: 28170282
Drug: Diskus (600 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diskus (600 μg dose)
Trial: 28170282
Drug: MDI (600 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDI (600 μg dose)
Trial: 23839182
Drug: Doxycycline calcium
RxNorm normalized name: Doxycycline Calcium
DrugBank: Doxycycline (DB00254)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Doxycycline calcium 0.6 mg/kg/day